Ledger.Open graph →
SEC Form D · filed October 3, 2022

BigHat Biosciences, Inc

Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN MATEO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Francisco Gimenez · San Mateo, CADirectorVineeta Agarwala · San Mateo, CADirectorSteve Kafka · San Mateo, CADirectorRobert Chess · San Mateo, CADirectorPeyton Greenside · San Mateo, CAExec · DirectorJoel Brown · Sidney, MTDirectorKaleb Dasinger · Sidney, MTExec · DirectorJames Lee · Sidney, MTDirectorSpencer Clawson · Salt Lake City, UTDirectorMichael Ulliman · New York, NYDirectorMark Depristo · San Carlos, CAExec · DirectorScott Richardson · New York, NYDirectorEmory L. Lowe · PEACHTREE CORNERS, GADirectorRaymond Debbane · New York, NYExec · DirectorMassandra Capital VIII, LLC · Irvine, CADirectorYolanda Banks Mccoy · George Town, Grand Cayman, Cayman IslandsDirectorMark Depristo · San Carlos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗